Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child

BACKGROUND A substantial proportion of perinatally acquired infections with the human immunodeficiency virus type 1 (HIV-1) occur at or near delivery, which suggests that obstetrical factors may have an important influence on transmission. We evaluated the relation of such factors and other variables to the perinatal transmission of HIV-1. METHODS The Women and Infants Transmission Study is a prospective, observational study of HIV-1-infected women who were enrolled during pregnancy and followed with their infants for three years after delivery. We studied obstetrical, clinical, immunologic, and virologic data on 525 women who delivered live singleton infants whose HIV-1-infection status was known as of August 31, 1994. RESULTS Among mothers with membranes that ruptured more than four hours before delivery, the rate of transmission of HIV-1 to the infants was 25 percent, as compared with 14 percent among mothers with membranes that ruptured four hours or less before delivery. In a multivariate analysis, the presence of ruptured membranes for more than four hours nearly doubled the risk of transmission (odds ratio, 1.82; 95 percent confidence interval, 1.10 to 3.00; P = 0.02), regardless of the mode of delivery. The other maternal factors independently associated with transmission were illicit-drug use during pregnancy (odds ratio, 1.90; 95 percent confidence interval, 1.14 to 3.16; P = 0.01), low antenatal CD4+ lymphocyte count (<29 percent of total lymphocytes) (odds ratio, 2.82; 1.67 to 4.76; P<0.001), and birth weight <2500 g (odds ratio, 1.86; 1.03 to 3.34; P = 0.04). CONCLUSIONS The risk of transmission of HIV-1 from mother to infant increases when the fetal membranes rupture more than four hours before delivery.

[1]  L. Mofenson,et al.  Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission , 1996, AIDS.

[2]  M. Sim,et al.  Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. , 1996, JAMA.

[3]  D. Thea,et al.  Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group. , 1995, Pediatrics.

[4]  J. Goedert,et al.  The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus , 1995 .

[5]  G. Pardi,et al.  The incidence of complications after caesarean section in 156 HIV‐positive women , 1995, AIDS.

[6]  J. Goedert,et al.  Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins. , 1995, The Journal of pediatrics.

[7]  L. Mofenson,et al.  A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency virus , 1995, The Pediatric infectious disease journal.

[8]  C. Rouzioux,et al.  Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study: 7 years of follow-up observation. The French Pediatric HIV Infection Study Group. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[9]  R. Gelber,et al.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. , 1994, The New England journal of medicine.

[10]  L. Mofenson,et al.  The role of obstetric interventions in the prevention of pediatric human immunodeficiency virus infection. , 1994, American journal of obstetrics and gynecology.

[11]  J. Goedert,et al.  Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. Perinatal AIDS Collaborative Transmission Studies. , 1994, Journal of acquired immune deficiency syndromes.

[12]  D. Brambilla,et al.  Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. The Women and Infants Transmission Study Group. , 1994, The Journal of infectious diseases.

[13]  N. Shaffer,et al.  A prospective population-based study of HIV perinatal transmission , 1994, AIDS.

[14]  J. Goedert,et al.  Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels. , 1994, Journal of acquired immune deficiency syndromes.

[15]  W. Tsai,et al.  Maternal-infant HIV transmission and circumstances of delivery. , 1994, American journal of public health.

[16]  Y. Bryson,et al.  Factors predictive of maternal-fetal transmission of HIV-1-preliminary analysis of zidovudine given during pregnancy and/or delivery , 1994 .

[17]  G. Pardi,et al.  Caesarean section and risk of vertical transmission of HIV-1 infection , 1994, The Lancet.

[18]  M. Essex,et al.  Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women , 1994, The Lancet.

[19]  G. Pardi,et al.  Perinatal findings in children born to HIV‐infected mothers , 1994, British journal of obstetrics and gynaecology.

[20]  O. Bagasra,et al.  Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. , 1993, The Journal of infectious diseases.

[21]  T. Chalmers,et al.  Cesarean section to reduce perinatal transmission of human immunodeficiency virus. A metaanalysis. , 1993, The Online journal of current clinical trials.

[22]  A. Landay,et al.  Prediction of CD4 count from CD4 percentage: experience from three laboratories. , 1993, AIDS.

[23]  T. Quinn,et al.  Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. , 1993, JAMA.

[24]  K. Holmes,et al.  Detection of HIV DNA in cervical and vaginal secretions: Prevalence and correlates among women in Nairobi, Kenya , 1993, JAMA.

[25]  E. Karita,et al.  Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) and its determinants: a cohort study in Kigali, Rwanda. , 1993, American journal of epidemiology.

[26]  S. Seiden,et al.  Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. , 1993, Journal of acquired immune deficiency syndromes.

[27]  L. Montagnier,et al.  Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. , 1993, Journal of acquired immune deficiency syndromes.

[28]  C. Giaquinto,et al.  Risk factors for mother‐to‐child transmission of HIV‐1 , 1992 .

[29]  C. Griscelli,et al.  The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates , 1992, The New England journal of medicine.

[30]  C. Giaquinto,et al.  Mother-to-child transmission of human immunodeficiency virus type 1: risk of infection and correlates of transmission. , 1992, Pediatrics.

[31]  F. Dabis,et al.  Characteristics of newborns and HIV-1 infection in Rwanda. , 1992, AIDS.

[32]  J. Bremer,et al.  Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories , 1992, Journal of clinical microbiology.

[33]  J. Goedert,et al.  Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1. , 1992, The Journal of clinical investigation.

[34]  R. Henrion,et al.  HIV replication during the first weeks of life , 1992, The Lancet.

[35]  B. Wahrén,et al.  Lack of association between maternal antibodies to V3 loop peptides and maternal-infant HIV-1 transmission. , 1992, Journal of acquired immune deficiency syndromes.

[36]  J. Goedert,et al.  High risk of HIV-1 infection for first-born twins , 1991, The Lancet.

[37]  S. Lindgren,et al.  HIV and child-bearing: clinical outcome and aspects of mother-to-infant transmission. , 1991, AIDS.

[38]  A. Sönnerborg,et al.  HIV in pregnant women and their offspring: evidence for late transmission , 1991, The Lancet.

[39]  C. Ou,et al.  Advances and problems in the diagnosis of human immunodeficiency virus infection in infants. , 1991, The Pediatric infectious disease journal.

[40]  H. Balfour,et al.  Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. , 1991, Journal of immunology.

[41]  H. Balfour,et al.  Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. , 1990, AIDS.

[42]  A. Rubinstein,et al.  Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[43]  B. Wahrén,et al.  Mother-to-infant transmission of HIV , 1990, The Lancet.

[44]  P. Selwyn,et al.  Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers , 1989, Disease markers.

[45]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[46]  J. Goedert,et al.  MOTHER-TO-INFANT TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1: ASSOCIATION WITH PREMATURITY OR LOW ANTI-gp120 , 1989, The Lancet.

[47]  T. Quinn,et al.  Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. , 1989, The New England journal of medicine.

[48]  J M Taylor,et al.  CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. , 1989, Journal of acquired immune deficiency syndromes.

[49]  D. Corcoran,et al.  Circulating lymphocyte subpopulations in pregnancy: a longitudinal study. , 1984, Journal of immunology.

[50]  B. Sachs,et al.  Cesarean section. Risk and benefits for mother and fetus. , 1983, JAMA.

[51]  Nitin R. Patel,et al.  A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables , 1983 .

[52]  Arthur Schafer,et al.  Ethics of the randomized clinical trial. , 1982, The New England journal of medicine.

[53]  P. Greipp,et al.  Decreased levels of helper T cells in pregnancy. , 1982, The New England journal of medicine.

[54]  W. Cleveland Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .